Search - tctmd.com

Displaying 41 - 60 of 251

Sort: Relevancy | Date

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Daily News

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

L.A. McKeown

December 28, 2021

News Daily News

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

Caitlin E. Cox

December 09, 2021

News Conference News ESC 2021

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

Shelley Wood

September 02, 2021

News Conference News ESC 2021

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Shelley Wood

August 28, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Daily News

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Yael L. Maxwell

April 09, 2021

News Daily News

Observational Study Supports Continuing Oral Anticoagulation During PCI

Michael O'Riordan

April 06, 2021

News Daily News

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

L.A. McKeown

April 05, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2021

Shelley Wood

March 02, 2021

News Daily News

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

Todd Neale

February 09, 2021

News Daily News

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

Michael O'Riordan

January 05, 2021

News Daily News

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Todd Neale

December 22, 2020

News Daily News

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

Caitlin E. Cox

November 06, 2020

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

News Industry News

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

October 17, 2020

News Daily News

More Insights Into AAA Genetics Spur New Questions on Screening

Caitlin E. Cox

September 29, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

Advertisement

Guideline-Directed Therapies Underused in Frail HF Patients

Surgeon Groups Explain Why They Didn’t Endorse New CAD Revascularization Guidelines

The ‘Black Box’ of Asymptomatic, Stable, Ischemic CAD Treated With PCI

OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT

MASTER DAPT: One Month's Enough in Patients at High Bleeding Risk

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI

Observational Study Supports Continuing Oral Anticoagulation During PCI

Antithrombotics for Elderly CAD Patients: One Size Doesn’t Fit All

TCTMD’s Top 10 Most Popular Stories for February 2021

Experts Update Antithrombotic Advice in AF Patients Undergoing PCI

Stable CAD With High-Risk Anatomy Warrants PCI or CABG, APPROACH Suggests

ACC Issues New Guidance Around Antithrombotic Choices in A-fib, VTE

Bleeds on Anticoagulants for A-Fib Can Unveil Occult Cancers

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial Evaluating 14-Days DAPT in Complex Patients at High Bleeding Risk Following PCI

More Insights Into AAA Genetics Spur New Questions on Screening

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content